Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM9U4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $73,044
Award facts
- Contract value 100% obligated
- $73,044.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $73,044.05 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 13, 2026, for the supply of Zepbound 7.5 mg/0.5 mL pens with an ultimate completion date of January 14, 2026. Zepbound is a semaglutide-based medication used for weight management treatment. The contract was competitively awarded with no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor serving federal healthcare systems.
This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive pharmaceutical supply vehicle supporting military healthcare programs globally, enabling the delivery of a broad range of medications, vaccines, medical devices, and specialty pharmaceuticals to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's extensive federal contracting portfolio demonstrates its established capability to fulfill critical medical supply needs for the Department of Defense and related military medical institutions.
Quick answers
Who was awarded contract SPE2DR26FM9U4?
SPE2DR26FM9U4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FM9U4 worth?
The government has obligated $73,044 on SPE2DR26FM9U4.
Is contract SPE2DR26FM9U4 an order under another contract?
Yes. SPE2DR26FM9U4 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM9U4 competed?
The extent of competition for SPE2DR26FM9U4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award